The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Clinical Management of Staphylococcus aureus Bacteremia: A Review
Open accessAbstract
IMPORTANCE: Several management strategies may improve outcomes in patients with Staphylococcus aureus bacteremia. OBJECTIVES: To review evidence of management strategies for S. aureus bacteremia to determine whether transesophageal echocardiography is necessary in all adult cases and what is the optimal antibiotic therapy for methicillin-resistant S. aureus (MRSA) bacteremia. EVIDENCE REVIEW: A PubMed search from inception through May 2014 was performed to identify studies addressing the role of transesophageal echocardiography in S. aureus bacteremia. A second search of PubMed, EMBASE, and the Cochrane Library from January 1990 through May 2014 was performed to find studies addressing antibiotic treatment for MRSA bacteremia. Studies reporting outcomes from antibiotic therapy for MRSA bacteremia were included. All searches, which were limited to English and focused on adults, were augmented by review of bibliographic references from included studies. The quality of evidence was assessed using the Grades of Recommendation, Assessment, Development and Evaluation system with consensus of independent evaluations by at least 2 of the authors. FINDINGS: In 9 studies with a total of 4050 patients, use of transesophageal echocardiography was associated with higher rates of a diagnosis of endocarditis (14%-28%) compared with transthoracic echocardiography (2%-15%). In 4 studies, clinical or transthoracic echocardiography findings did not predict subsequent transesophageal echocardiography findings of endocarditis. Five studies identified clinical or transthoracic echocardiography characteristics associated with low risk of endocarditis (negative predictive values from 93% to 100%). Characteristics associated with a low risk of endocarditis include absence of a permanent intracardiac device, sterile follow-up blood cultures within 4 days after the initial set, no hemodialysis dependence, nosocomial acquisition of S. aureus bacteremia, absence of secondary foci of infection, and no clinical signs of infective endocarditis. Of 81 studies of antibiotic therapy for MRSA bacteremia, only 1 high-quality trial was identified. In that study of 246 patients with S. aureus bacteremia, daptomycin was not inferior to vancomycin or an antistaphylococcal penicillin, each in combination with low-dose, short-course gentamicin (clinical success rate, 44.2% [53/120] vs 41.7% [48/115]; absolute difference, 2.4% [95% CI, -10.2% to 15.1%]). CONCLUSIONS AND RELEVANCE: All adult patients with S. aureus bacteremia should undergo echocardiography. Characteristics of low-risk patients with S. aureus bacteremia for whom transesophageal echocardiography can be safely avoided have been identified. Vancomycin and daptomycin are the first-line antibiotic choices for MRSA bacteremia. Well-designed studies to address the management of S. aureus bacteremia are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Self-citationMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Self-citationStaphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Self-citationPredictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Allergy Diagnostic Testing: An Updated Practice Parameter
Bernstein, I. L., Li, J. T., Bernstein, D. I., Hamilton, R., Spector, S. L., Tan, R., Sicherer, S., Golden, D. B. K., Khan, D. A., Nicklas, R. A., et al. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60305-5 · Cited by 723
Thuny, F., Disalvo, G., Belliard, O., Avierinos, J.-F., Pergola, V., Rosenberg, V., Casalta, J.-P., Gouvernet, J., Derumeaux, G., Iarussi, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.493155 · Cited by 703
Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler, V. G., Olsen, M. K., Corey, G. R., Woods, C. W., Cabell, C. H., Reller, L. B., Cheng, A. C., Dudley, T., & Oddone, E. Z. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.17.2066 · Cited by 652
Self-citationLevine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir935 · Cited by 512
Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463 · cited 1×
“Levine et al,45 1991 (openlabel RCT) Moderate 42 MRSA endocarditis (median [range] age of 32 [23-61] y); treatment with vancomycin alone (1 g every 12 h; n = 22) vs vancomycin (1 g every 12 h) plus rifampin (600 mg/d) (n = 20) Duration of bacteremia Median duration of 9 d for bacteremia for all patients; 7 (95% CI, 5…”
Fowler, V. G., Sanders, L. L., Sexton, D. J., Kong, L., Marr, K. A., Gopal, A. K., Gottlieb, G., McClelland, R. S., & Corey, G. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514686 · Cited by 441
Self-citationBirmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428
Fowler, V. G., Li, J., Corey, G. R., Boley, J., Marr, K. A., Gopal, A. K., Kong, L. K., Gottlieb, G., Donovan, C. L., Sexton, D. J., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00250-7 · Cited by 423
Self-citationKORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355
Stryjewski, M. E., Szczech, L. A., Benjamin, D. K., Inrig, J. K., Kanafani, Z. A., Engemann, J. J., Chu, V. H., Joyce, M. J., Reller, L. B., Corey, G. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510386 · Cited by 348
Self-citationMarkowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343 · cited 1×
“Levine et al,45 1991 (openlabel RCT) Moderate 42 MRSA endocarditis (median [range] age of 32 [23-61] y); treatment with vancomycin alone (1 g every 12 h; n = 22) vs vancomycin (1 g every 12 h) plus rifampin (600 mg/d) (n = 20) Duration of bacteremia Median duration of 9 d for bacteremia for all patients; 7 (95% CI, 5…”
Staphylococcus aureus bacteremia
Nolan, C. M., & Beaty, H. N. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90715-4 · Cited by 314
Initial Low‐Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Cosgrove, S. E., Vigliani, G. A., Campion, M., Fowler, Jr., Abrutyn, E., Corey, G. R., Levine, D. P., Rupp, M. E., Chambers, H. F., Karchmer, A. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597031 · Cited by 309
Kim, S.-H., Kim, K.-H., Kim, H.-B., Kim, N.-J., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-07 · Cited by 300
Raad, I., Darouiche, R., Vazquez, J., Lentnek, A., Hachem, R., Hanna, H., Goldstein, B., Henkel, T., & Seltzer, E. (2005) · Clinical Infectious Diseases · doi:10.1086/427283 · Cited by 292
Heldman, A. W., Hartert, T. V., Ray, S. C., Daoud, E. G., Kowalski, T. E., Pompili, V. J., Sisson, S. D., Tidmore, W. C., vom Eigen, K. A., Goodman, S. N., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00070-8 · Cited by 289
Kaasch, A. J., Barlow, G., Edgeworth, J. D., Fowler, V. G., Hellmich, M., Hopkins, S., Kern, W. V., Llewelyn, M. J., Rieg, S., Rodriguez-Baño, J., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2013.10.015 · Cited by 277
Self-citationSchweizer, M. L., Furuno, J. P., Harris, A. D., Johnson, J. K., Shardell, M. D., McGregor, J. C., Thom, K. A., Cosgrove, S. E., Sakoulas, G., & Perencevich, E. N. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-279 · Cited by 254
Dhand, A., Bayer, A. S., Pogliano, J., Yang, S.-J., Bolaris, M., Nizet, V., Wang, G., & Sakoulas, G. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir340 · Cited by 252 · cited 1×
“Levine et al,45 1991 (openlabel RCT) Moderate 42 MRSA endocarditis (median [range] age of 32 [23-61] y); treatment with vancomycin alone (1 g every 12 h; n = 22) vs vancomycin (1 g every 12 h) plus rifampin (600 mg/d) (n = 20) Duration of bacteremia Median duration of 9 d for bacteremia for all patients; 7 (95% CI, 5…”
Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
Rubinstein, E., Lalani, T., Corey, G. R., Kanafani, Z. A., Nannini, E. C., Rocha, M. G., Rahav, G., Niederman, M. S., Kollef, M. H., Shorr, A. F., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq031 · Cited by 246
Landrum, M. L., Neumann, C., Cook, C., Chukwuma, U., Ellis, M. W., Hospenthal, D. R., & Murray, C. K. (2012) · JAMA · doi:10.1001/jama.2012.7139 · Cited by 228
Wilcox, M. H., Tack, K. J., Bouza, E., Herr, D. L., Ruf, B. R., Ijzerman, M. M., Croos‐Dabrera, R. V., Kunkel, M. J., & Knirsch, C. (2009) · Clinical Infectious Diseases · doi:10.1086/595686 · Cited by 223
Moore, C. L., Osaki-Kiyan, P., Haque, N. Z., Perri, M. B., Donabedian, S., & Zervos, M. J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir764 · Cited by 220
Jenkins, T. C., Price, C. S., Sabel, A. L., Mehler, P. S., & Burman, W. J. (2008) · Clinical Infectious Diseases · doi:10.1086/529190 · Cited by 216
Shorr, A. F., Kunkel, M. J., & Kollef, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki355 · Cited by 198
Fowler, Jr., Sanders, L. L., Kong, L. K., McClelland, R. S., Gottlieb, G. S., Li, J., Ryan, T., Sexton, D. J., Roussakis, G., Harrell, L. J., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515076 · Cited by 196
The Value of Infectious Diseases Consultation in Staphylococcus aureus Bacteremia
Honda, H., Krauss, M. J., Jones, J. C., Olsen, M. A., & Warren, D. K. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.01.015 · Cited by 189
Rosen, A. B., Fowler, V. G., Corey, G. R., Downs, S. M., Biddle, A. K., Li, J., & Jollis, J. G. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00004 · Cited by 186
Self-citationRieg, S., Peyerl-Hoffmann, G., de With, K., Theilacker, C., Wagner, D., Hübner, J., Dettenkofer, M., Kaasch, A., Seifert, H., Schneider, C., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.07.015 · Cited by 181
Murray, K. P., Zhao, J. J., Davis, S. L., Kullar, R., Kaye, K. S., Lephart, P., & Rybak, M. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit112 · Cited by 178
Kaech, C., Elzi, L., Sendi, P., Frei, R., Laifer, G., Bassetti, S., & Flückiger, U. M. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01359.x · Cited by 174
Gould, F. K., Brindle, R. J., Chadwick, P. R., Fraise, A. P., Hill, S., Nathwani, D., Ridgway, G. L., Spry, M. J., Warren, R. E., & on behalf of the MRSA Working Party of the British Society for Antimicrobial Chemotherapy (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp065 · Cited by 173
Stryjewski, M. E., O'Riordan, W. D., Lau, W. K., Pien, F. D., Dunbar, L. M., Vallee, M., Fowler, V. G., Chu, V. H., Spencer, E., Barriere, S. L., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429914 · Cited by 173
Self-citationCounterpoint: Vancomycin and Staphylococcus aureus--An Antibiotic Enters Obsolescence
Deresinski, S. (2007) · Clinical Infectious Diseases · doi:10.1086/518452 · Cited by 173
Dworkin, R. J., Sande, M. A., Lee, B. L., & Chambers, H. F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91083-0 · Cited by 170
Rasmussen, R. V., Host, U., Arpi, M., Hassager, C., Johansen, H. K., Korup, E., Schonheyder, H. C., Berning, J., Gill, S., Rosenvinge, F. S., et al. (2011) · European Journal of Echocardiography · doi:10.1093/ejechocard/jer023 · Cited by 169
Self-citationDrew, R. H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.775 · Cited by 165
Khatib, R., Saeed, S., Sharma, M., Riederer, K., Fakih, M. G., & Johnson, L. B. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0096-0 · Cited by 156
(1990) · Infectious Diseases Newsletter · doi:10.1016/0278-2316(90)90059-o · Cited by 151
Short-Course Therapy of Catheter-related Staphylococcus aureus Bacteremia
Jernigan, J. A., & Farr, B. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-4-199308150-00010 · Cited by 147
Infectious Diseases Consultation Lowers Mortality From Staphylococcus aureus Bacteremia
Lahey, T., Shah, R., Gittzus, J., Schwartzman, J. D., & Kirkland, K. B. (2009) · Medicine · doi:10.1097/md.0b013e3181b8fccb · Cited by 143
Kullar, R., Davis, S. L., Levine, D. P., Zhao, J. J., Crank, C. W., Segreti, J., Sakoulas, G., Cosgrove, S. E., & Rybak, M. J. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.6.527 · Cited by 136
Kaasch, A. J., Fowler, V. G., Rieg, S., Peyerl‐Hoffmann, G., Birkholz, H., Hellmich, M., Kern, W. V., & Seifert, H. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir320 · Cited by 136
Self-citationForsblom, E., Ruotsalainen, E., Ollgren, J. P., & Järvinen, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis889 · Cited by 135
van Hal, S. J., & Fowler, V. G. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit178 · Cited by 126
Self-citationChong, Y. P., Moon, S. M., Bang, K. M., Park, H. J., Park, S.-Y., Kim, M., Park, K., Kim, S., Lee, S., Choi, S., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01021-12 · Cited by 124
Jang, H., Kim, S., Kim, K. H., Kim, C. J., Lee, S., Song, K., Jeon, J. H., Park, W. B., Kim, H. B., Park, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/600295 · Cited by 113 · cited 1×
“Levine et al,45 1991 (openlabel RCT) Moderate 42 MRSA endocarditis (median [range] age of 32 [23-61] y); treatment with vancomycin alone (1 g every 12 h; n = 22) vs vancomycin (1 g every 12 h) plus rifampin (600 mg/d) (n = 20) Duration of bacteremia Median duration of 9 d for bacteremia for all patients; 7 (95% CI, 5…”
Lodise, T. P., McKinnon, P. S., Levine, D. P., & Rybak, M. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00101-07 · Cited by 113
Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy
Casapao, A. M., Davis, S. L., Barr, V. O., Klinker, K. P., Goff, D. A., Barber, K. E., Kaye, K. S., Mynatt, R. P., Molloy, L. M., Pogue, J. M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02371-13 · Cited by 108
Robinson, J. O., Langhi, S., Phillips, M. R., Pearson, J. C., Christiansen, K., Coombs, G. W., & Murray, R. J. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1585-y · Cited by 106
Carugati, M., Bayer, A. S., Miró, J. M., Park, L. P., Guimarães, A. C., Skoutelis, A., Fortes, C. Q., Durante-Mangoni, E., Hannan, M. M., Nacinovich, F., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01563-13 · Cited by 100
Self-citationPredicting Risk for Death from MRSA Bacteremia1
Pastagia, M., Kleinman, L. C., Lacerda, E., & Jenkins, S. G. (2012) · Emerging infectious diseases · doi:10.3201/eid1807.101371 · Cited by 98
GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009)
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U., Lekakis, J. P., et al. (2010) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2010-6-5-733-746 · Cited by 96
Dilworth, T. J., Ibrahim, O. M., Hall, P. R., Sliwinski, J., Walraven, C. J., & Mercier, R.-C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01204-13 · Cited by 95
Gardiner, D., Dukart, G., Cooper, A., & Babinchak, T. (2009) · Clinical Infectious Diseases · doi:10.1086/648720 · Cited by 91
The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
McConeghy, K. W., Bleasdale, S. C., & Rodvold, K. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit560 · Cited by 90
Nagao, M., Iinuma, Y., SAITO, T. K., Matsumura, Y., Shirano, M., Matsushima, A., Takakura, S., Ito, Y., & Ichiyama, S. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03156.x · Cited by 86
Gómez, J., García-Vázquez, E., Baños, R., Canteras, M., Ruiz, J., Baños, V., Herrero, J. A., & Valdés, M. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0272-x · Cited by 81
Menichetti, F., Martino, P., Bucaneve, G., Gentile, G., D’Antonio, D., Liso, V., Ricci, P., Nosari, A., Buelli, M., & Carotenuto, M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2041 · Cited by 77
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality
Tissot, F., Calandra, T., Prod’hom, G., Taffé, P., Zanetti, G. M. R., Greub, G., & Senn, L. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.05.004 · Cited by 75
Atrouni, W. E., Knoll, B. M., Lahr, B. D., Eckel‐Passow, J. E., Sia, I. G., & Baddour, L. M. (2009) · Clinical Infectious Diseases · doi:10.1086/648442 · Cited by 71
Stryjewski, M. E., Lentnek, A. L., O’Riordan, W. D., Pullman, J. R., Tambyah, P. A., Miró, J. M., Fowler, V. G., Barriere, S. L., Kitt, M. M., & Corey, G. R. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-289 · Cited by 69
Self-citationPrioritizing echocardiography in Staphylococcus aureus bacteraemia
Joseph, J. P., Meddows, T. R., Webster, D. P., Newton, J. D., Myerson, S. G., Prendergast, B. D., Scarborough, M., & Herring, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks408 · Cited by 69
Sullenberger, A. L., Avedissian, L. S., & Kent, S. M. (2005) · PubMed · Cited by 64
Echocardiography Is Dispensable in Uncomplicated Staphylococcus aureus Bacteremia
Khatib, R., & Sharma, M. (2013) · Medicine · doi:10.1097/md.0b013e318294a710 · Cited by 61
Incani, A., Hair, C., Purnell, P., O'Brien, D. P., Cheng, A. C., Appelbe, A., & Athan, E. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1838-4 · Cited by 57
Goldberg, E., Paul, M., Talker, O., Samra, Z., Raskin, M., Hazzan, R., Leibovici, L., & Bishara, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq179 · Cited by 55
van Hal, S. J., Mathur, G., Kelly, J. J., Aronis, C., Cranney, G. B., & Jones, P. D. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.01.011 · Cited by 53
Yoon, Y. K., Park, D. W., Sohn, J. W., Kim, H. Y., Ys, K., Lee, C., Lee, M. S., Ryu, S. Y., Jang, H., Choi, Y. J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00520-13 · Cited by 52
Pragman, A. A., Kuskowski, M. A., Abraham, J. M., & FILICE, G. A. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318255d67c · Cited by 51
Casella, F., Rana, B. S., Casazza, G., Bhan, A., Kapetanakis, S., Omigie, J., Reiken, J., & Monaghan, M. J. (2009) · Echocardiography · doi:10.1111/j.1540-8175.2009.00906.x · Cited by 47
Infectious Diseases Consultation and the Management of Staphylococcus aureus Bacteremia
Fries, B., Licitra, C. M., Crespo, A., Akhter, K., Busowski, M. T., Salazar, D., & Wallace, M. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit730 · Cited by 46
Dodek, P., & Phillips, P. (1999) · Clinical Infectious Diseases · doi:10.1086/313435 · Cited by 45
Moore, C. L., Lü, M., Cheema, F., Osaki-Kiyan, P., Perri, M. B., Donabedian, S. M., Haque, N. Z., & Zervos, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00115-11 · Cited by 43
Park, H. J., Kim, S., Kim, M.-J., Lee, Y., Park, S.-Y., Moon, S. M., Park, K., Chong, Y. P., Lee, S., Choi, S., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.08.007 · Cited by 40
Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan
Isobe, M., Seki, M., Yamagishi, Y., Miyawaki, K., Yabuno, K., Hamaguchi, S., Yoshioka, N., Tomono, K., Isobe, M., Uejima, E., et al. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0423-6 · Cited by 35
Forstner, C., Dungl, C., Tobudic, S., Mitteregger, D., Lagler, H., & Burgmann, H. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12169 · Cited by 32
Choi, S.-H., Cho, S. Y., Park, J., & Chung, J.-W. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.12.002 · Cited by 30
Hall, R. G., Giuliano, C. A., Haase, K. K., Hazlewood, K. A., Frei, C. R., Forcade, N. A., Brouse, S. D., Bell, T., Bedimo, R., & Álvarez, C. A. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-104 · Cited by 28
Holden, E., Bashir, A. M., Das, I., Morton, H., Steadman, C. D., Nightingale, P., Steeds, R. P., & David, M. D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku082 · Cited by 24
Lemonovich, T. L., Haynes, K., Lautenbach, E., & Amorosa, V. K. (2011) · Infection · doi:10.1007/s15010-011-0189-2 · Cited by 18
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia
Stryjewski, M. E., Barriere, S. L., Rubinstein, E., Genter, F. C., Lentnek, A. L., Magaña-Aquino, M., Luna, C. M., Niederman, M. S., Torres, A., & Corey, G. R. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.003 · Cited by 17
Soriano, À., & Mensa, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir305 · Cited by 5
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Self-citationHassoun, A., Linden, P. K., & Friedman, B. (2017) · Critical Care · doi:10.1186/s13054-017-1801-3 · Cited by 604
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
Self-citationStaphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis
Bai, A. D., Lo, C. K. L., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Del Corpo, O., Stefanova, I., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.03.015 · Cited by 319
Pathogenesis of Staphylococcus aureus Bloodstream Infections
Thomer, L., Schneewind, O., & Missiakas, D. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044351 · Cited by 292
Metadata
- Authors
- Holland, T. L., Arnold, C., & Fowler, V. G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-10-01
- Volume
- 312
- Issue
- 13
- Pages
- 1330
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2056229483
- Cited by
- 449
- References
- 96
- FWCI
- 24.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.